Huaizhong Health (ADAD) 10-K 27 Mar 23 2022 FY Annual report Financial data

Cover

Cover - USD ($)	12 Months Ended
	Oct. 31, 2022	Mar. 31, 2023	Apr. 30, 2022
Cover [Abstract]
Entity Registrant Name	HUAIZHONG HEALTH GROUP, INC.
Entity Central Index Key	0001593204
Document Type	10-K
Amendment Flag	false
Entity Voluntary Filers	No
Current Fiscal Year End Date	--10-31
Entity Well Known Seasoned Issuer	No
Entity Small Business	true
Entity Shell Company	true
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Document Period End Date	Oct. 31, 2022
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2022
Entity Common Stock Shares Outstanding		31,518,466
Entity Public Float			$ 1,408,560
Document Annual Report	true
Document Transition Report	false
Entity File Number	000-55369
Entity Incorporation State Country Code	NV
Entity Tax Identification Number	90-1020141
Entity Interactive Data Current	Yes
Icfr Auditor Attestation Flag	false
Entity Address Address Line 1	Tianan Technology Park
Entity Address Address Line 2	13/F Headquarters Center Building 16
Entity Address Address Line 3	555 Panyu North Ave, Panyu District
Entity Address City Or Town	Guangzhou City
City Area Code	86 (20)
Local Phone Number	2982 9356
Entity Address Country	CN
Security 12g Title	Common Stock, $0.001 par value
Auditor Firm Id	6108
Auditor Location	Vancouver, Washington
Auditor Name	MICHAEL GILLESPIE & ASSOCIATES, PLLC

Balance Sheets

Balance Sheets - USD ($)	Oct. 31, 2022	Oct. 31, 2021
Current Assets
Cash	$ 0	$ 0
Prepaid expenses	1,250	0
Total Current Assets	1,250	0
Total Assets	1,250	0
Current Liabilities
Accounts payable	9,800	9,950
Due to related party	70,922	40,351
Total Current Liabilities	80,722	50,301
Total Liabilities	80,722	50,301
Stockholders' Deficit
Common stock: 750,000,000 shares authorized; $0.001 par value 31,518,466 issued and outstanding	31,518	31,518
Additional paid in capital	257,587	257,587
Accumulated deficit	(368,577)	(339,406)
Total Stockholders' Deficit	(79,472)	(50,301)
Total Liabilities and Stockholders' Deficit	$ 1,250	$ 0

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - $ / shares	Oct. 31, 2022	Oct. 31, 2021
Balance Sheets
Common stock, par value	$ 0.001	$ 0.001
Common stock shares authorized	750,000,000	750,000,000
Common stock shares issued	31,518,466	31,518,466
Common stock shares outstanding	31,518,466	31,518,466

Statements of Operations

Statements of Operations - USD ($)	12 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Statements of Operations
Revenue	$ 0	$ 0
Operating Expenses:
Professional fees	26,175	27,919
General and administrative	2,996	2,910
Total operating expenses	29,171	30,829
Operating Loss	(29,171)	(30,829)
Net loss before taxes	(29,171)	(30,829)
Income tax benefit	0	0
Net Loss	$ (29,171)	$ (30,829)
Net loss per common share, basic and diluted	$ 0	$ 0
Basic and diluted weighted average common shares outstanding	31,518,466	31,518,466

Statements of Changes in Stockh

Statements of Changes in Stockholders Deficit - USD ($)	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit
Balance, shares at Oct. 31, 2020		31,518,466
Balance, amount at Oct. 31, 2020	$ (19,472)	$ 31,518	$ 257,587	$ (308,577)
Net loss	(30,829)	$ 0	0	(30,829)
Balance, shares at Oct. 31, 2021		31,518,466
Balance, amount at Oct. 31, 2021	(50,301)	$ 31,518	257,587	(339,406)
Net loss	(29,171)	$ 0	0	(29,171)
Balance, shares at Oct. 31, 2022		31,518,466
Balance, amount at Oct. 31, 2022	$ (79,472)	$ 31,518	$ 257,587	$ (368,577)

Statement of Cash Flows

Statement of Cash Flows - USD ($)	12 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (29,171)	$ (30,829)
Changes in current assets and liabilities:
Prepaid expenses	(1,250)	0
Accounts payable and accrued liabilities	(150)	(963)
Net cash used in operating activities	(30,571)	(31,792)
CASH FLOWS FROM FINANCING ACTIVITIES
Related party advances funding operations	30,571	31,792
Net cash provided by financing activities	30,571	31,792
Net change in cash for the period	0	0
Cash at beginning of period	0	0
Cash at end of period	0	0
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for income taxes	0	0
Cash paid for interest	$ 0	$ 0

Organization and Going Concern

Organization and Going Concern	12 Months Ended
	Oct. 31, 2022
Organization and Going Concern
Organization and Going Concern	Note 1 - Organization and Going Concern Adaiah Distribution, Inc. (the “Company”), is a for profit corporation established under the corporation laws in the State of Nevada, United States of America on September 12, 2013. Effective December 15, 2020, the company changed its operation name to Huaizhong Health Group, Inc. (the Company). Our principal office is located at Tianan Technology Park, 13/F Headquarters Center Building 16, 555 Panyu North Ave, Panyu District, Guangzhou City, China. The Company’s fiscal year end is October 31. The Company was in the development phase of its custom pillow distribution business. During the third fiscal quarter ending July 31, 2018, the Company had ceased its operations of its Pillow manufacturing and sales. The Company is not currently engaged in any business operations. It is however seeking to identify, locate and if warranted acquire new commercial opportunities. Going Concern The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. As of October 31, 2022, the Company has suffered recurring losses from operations, has an accumulated deficit of $368,577 and has not earned any revenues. The Company intends to fund operations through equity financing arrangements and related party advances, which may be insufficient to fund its capital expenditures, working capital and other cash requirements for the year ending October 31, 2023. The ability of the Company to emerge from an early stage is dependent upon, among other things, obtaining additional financing to continue operations, and development of its business plan. In response to these problems, management intends to raise additional funds through public or private placement offerings. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Significant Accounting Policies

Significant Accounting Policies and Recent Accounting Pronouncements	12 Months Ended
	Oct. 31, 2022
Significant Accounting Policies and Recent Accounting Pronouncements
Significant Accounting Policies and Recent Accounting Pronouncements	Note 2: Significant Accounting Policies and Recent Accounting Pronouncements Basis of Presentation The Financial Statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The Financial Statements have been prepared using the accrual basis of accounting in accordance with Generally Accepted Accounting Principles (“GAAP”) of the United States. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain expenses during the reporting period. Actual results could differ from these good faith estimates and judgments. Cash and Cash Equivalents Cash and cash equivalents include cash in hand and cash in time deposits, certificates of deposit and all highly liquid debt instruments with original maturities of three months or less. The Company had no cash and cash equivalents at October 31, 2022 and 2021, respectively. Fair Value of Measurements ASC 825, “Disclosures about Fair Value of Financial Instruments”, requires disclosure of fair value information about financial instruments. ASC 820, “Fair Value Measurements” defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of October 31, 2022 and 2021. The respective carrying values of certain on-balance-sheet financial instruments approximate their fair values. These financial instruments include accrued liabilities and notes payable. Fair values were assumed to approximate carrying values for these financial instruments since they are short term in nature and their carrying amounts approximate fair value. Basic and Diluted Loss Per Common Share The Company computes earnings (loss) per share in accordance with ASC 260-10-45 “Earnings per Share”, which requires presentation of both basic and diluted earnings per share on the face of the statement of operations. Basic earnings (loss) per share is computed by dividing net earnings (loss) available to common stockholders by the weighted average number of outstanding common shares during the period. Diluted earnings per share reflects the potential dilution that could occur if stock options and other commitments to issue common stock were exercised or equity awards vest resulting in the issuance of common stock that could share in the earnings of the Company. Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recorded to reduce the Company’s deferred tax assets to the amount that is more likely than not to be realized. Recent Accounting Pronouncements The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on our financial statements.

Stockholders Equity

Stockholders Equity	12 Months Ended
	Oct. 31, 2022
Stockholders Equity
Stockholders' Equity	Note 3 – Stockholders’ Equity The Company has 750,000,000 shares of common stock authorized with a par value of $0.001 per share. As of October 31, 2022, and 2021, there were 31,518,466 shares of common stock issued and outstanding.

Income Taxes

Income Taxes	12 Months Ended
	Oct. 31, 2022
Income Taxes
Income Taxes	Note 4 - Income Taxes The Company provides for income taxes under ASC 740, “Income Taxes.” Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax basis of assets and liabilities and the tax rates in effect when these differences are expected to reverse. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations. The components of the Company’s deferred tax asset and reconciliation of income taxes computed at the statutory rate of 21% to the income tax amount recorded as of October 31, 2022 and 2021 are as follows: October 31, October 31, 2022 2021 Net Operating Loss $ (29,171 ) $ (30,829 ) Effective tax rate 21 % 21 % Income Tax expense (6,126 ) (6,474 ) Less: valuation allowance 6,126 6,474 Income Tax Expense $ - $ - Net deferred tax assets consist of the following components as of October 31,2022 and 2021: October 31, October 31, 2022 2021 Net Operating Loss carryforward $ 77,401 $ 71,275 Valuation allowance (77,401 ) (71,275 ) Net deferred tax asset $ - $ - At October 31, 2022, the Company had $368,577 of net operating losses (“NOLs”). NOLs generated in tax years prior to July 31, 2018, can be carryforward for twenty years, whereas NOLs generated after July 31, 2018 can be carryforward indefinitely. The NOL carry forwards are subject to certain limitations due to the change in control of the Company pursuant to Internal Revenue Code Section 382. The Company experienced a change in control for tax purposes in August 2020. Due to change of control, the Company will not be able to carryover approximately $294,765 of NOL generated before August 12, 2020 to offset future income.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Oct. 31, 2022
Related Party Transactions
Related Party Transactions	Note 5 – Related Party Transactions During the years ended October 31,2022 and 2021, the Company’s sole officer and director advanced to the Company an amount of $30,571 and $31,792 by paying for expenses on behalf of the Company, respectively. As of October 31, 2022, and 2021, the Company was obligated to the officer, for an unsecured, non-interest-bearing demand loan with a balance of $70,922 and $40,351, respectively.

Subsequent Events

Subsequent Events	12 Months Ended
	Oct. 31, 2022
Subsequent Events
Subsequent Events	Note 6 – Subsequent Events The Company has evaluated subsequent events from October 31, 2021, through the date these financial statements were issued and determined no additional events to disclose, except as follows: The Company’s sole officer and director advanced to the Company an amount of $13,250 by paying for operating expenses on behalf of the Company.

Significant Accounting Polici_2

Significant Accounting Policies and Recent Accounting Pronouncements (Policies)	12 Months Ended
	Oct. 31, 2022
Significant Accounting Policies and Recent Accounting Pronouncements
Basis of Presentation	The Financial Statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The Financial Statements have been prepared using the accrual basis of accounting in accordance with Generally Accepted Accounting Principles (“GAAP”) of the United States.
Use of Estimates	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain expenses during the reporting period. Actual results could differ from these good faith estimates and judgments.
Cash and Cash Equivalents	Cash and cash equivalents include cash in hand and cash in time deposits, certificates of deposit and all highly liquid debt instruments with original maturities of three months or less. The Company had no cash and cash equivalents at October 31, 2022 and 2021, respectively.
Fair Value of Measurements	ASC 825, “Disclosures about Fair Value of Financial Instruments”, requires disclosure of fair value information about financial instruments. ASC 820, “Fair Value Measurements” defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of October 31, 2022 and 2021. The respective carrying values of certain on-balance-sheet financial instruments approximate their fair values. These financial instruments include accrued liabilities and notes payable. Fair values were assumed to approximate carrying values for these financial instruments since they are short term in nature and their carrying amounts approximate fair value.
Basic and Diluted Loss Per Common Share	The Company computes earnings (loss) per share in accordance with ASC 260-10-45 “Earnings per Share”, which requires presentation of both basic and diluted earnings per share on the face of the statement of operations. Basic earnings (loss) per share is computed by dividing net earnings (loss) available to common stockholders by the weighted average number of outstanding common shares during the period. Diluted earnings per share reflects the potential dilution that could occur if stock options and other commitments to issue common stock were exercised or equity awards vest resulting in the issuance of common stock that could share in the earnings of the Company.
Income Taxes	Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recorded to reduce the Company’s deferred tax assets to the amount that is more likely than not to be realized.
Recent Accounting Pronouncements	The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on our financial statements.

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Oct. 31, 2022
Income Taxes
Schedule of deferred tax asset and reconciliation of income taxes	October 31, October 31, 2022 2021 Net Operating Loss $ (29,171 ) $ (30,829 ) Effective tax rate 21 % 21 % Income Tax expense (6,126 ) (6,474 ) Less: valuation allowance 6,126 6,474 Income Tax Expense $ - $ -
Schedule of Net deferred tax assets	October 31, October 31, 2022 2021 Net Operating Loss carryforward $ 77,401 $ 71,275 Valuation allowance (77,401 ) (71,275 ) Net deferred tax asset $ - $ -

Organization and Going Concern

Organization and Going Concern (Details Narrative) - USD ($)	Oct. 31, 2022	Oct. 31, 2021
Organization and Going Concern
Accumulated deficit	$ (368,577)	$ (339,406)

Stockholders Equity (Details Na

Stockholders Equity (Details Narrative) - $ / shares	Oct. 31, 2022	Oct. 31, 2021
Stockholders Equity
Common stock, par value	$ 0.001	$ 0.001
Common stock shares authorized	750,000,000	750,000,000
Common stock shares issued	31,518,466	31,518,466
Common stock shares outstanding	31,518,466	31,518,466

Income Taxes (Details)

Income Taxes (Details) - USD ($)	12 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Income Taxes
Net Operating Loss	$ (29,171)	$ (30,829)
Effective tax rate	21%	21%
Income Tax expense	$ (6,126)	$ (6,474)
Less: valuation allowance	6,126	6,474
Income Tax Expense	$ 0	$ 0

Income Taxes (Details 1)

Income Taxes (Details 1) - USD ($)	Oct. 31, 2022	Oct. 31, 2021
Income Taxes
Net Operating Loss carryforward	$ 77,401	$ 71,275
Valuation allowance	(77,401)	(71,275)
Net deferred tax asset	$ 0	$ 0

Income Taxes (Details Narrative

Income Taxes (Details Narrative) - USD ($)	12 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Aug. 12, 2020
Net operating losses carryforward	$ (368,577)
Effective tax rate	21%	21%
Net operating losses	$ 368,577
Deferred Tax Assets [Member]
Net operating losses carryforward			$ (294,765)
Net operating losses			$ 294,765

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	12 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Related party advances funding operations	$ 30,571	$ 31,792
Due to related party	70,922	40,351
Sole Officer and Director [Member]
Related party advances funding operations	$ 30,571	$ 31,792

Subsequent Events (Details Narr

Subsequent Events (Details Narrative)	12 Months Ended
	Oct. 31, 2022 USD ($)
Sole Officer and Director [Member]
Payment for operating expenses	$ 13,250